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Structural-functional relationships in diabetic nephropathy. of the curves after digital subtraction of chamber echoes (fig 1) . Measurements were made-at 370C.
A multiple linear regression analysis was performed to study the relations between echogenicity, sedimentation rate, and packed cell volume. An intraclass correlation coefficient was used to describe the within subject component of variance of four different blood samples from the same subject in a series of four subjects.
Four different blood samples from the same subject in a series of four subjects (all healthy volunteers) were examined at intervals of 30 minutes to study the reproducibility of the method.
Results
Twenty subjects were excluded because of failure to measure the packed cell volume (n=5), the sample volume was too small (n=8), contamination of the sample (n=2), leakage of the tubing (n=2), and other recording errors (n= 3 higher echogenicity than the least echogenic sample of the 19 with a sedimentation rate above 30 mm in first hour.
Discussion
The measurement of erythrocvte sedimentation rate has been used to detect immunological, infective, ischaemic, malignant, and traumatic processes. As a screening test for acute phase response it has often been criticised, but is difficult to dislodge. Its most important disadvantages are its dependence on packed cell volume, difficulties with quality control, and the long duration of the test.' However, the International Committee for Standardisation in Haematology recommends the measurement of erythrocyte sedimentation rate together with plasma viscosity as the best method for monitoring long term changes in concentrations of proteins in the acute phase."
Erythrocyte aggregation is the basis for blood echogenicity. An index of red blood cell aggregation can be measured by determining whole blood echogenicity. The method detects very small changes in the concentration of macromolecules in the plasma.' Blood echogenicity is fairly independent of packed cell volume over a range from 0 10 to 0 80.'2 13 In a study on porcine blood there was no correlation between ultrasonic backscatter and packed cell volume at low shear rates.'4 In the present study there was no correlation between packed cell volume and blood echogenicity. At raised sedimentation rates anaemic blood seemed to be less echogenic than normal blood of similar sedimentation rate (fig 2) : the mean echogenicity of anaemic samples was 82% of that of normal blood when compared in samples with a high sedimentation rate (>50 mm in first hour).
Blood echogenicity is affected by several other factors in addition to plasma concentration of macromolecules. The most important of these are blood flow conditions,4" ultrasonic variables, and blood temperature. ' These should be standardised for echogenicity measurements.
The question of quality control of the ultrasonic method for determining erythrocyte sedimentation rate has not yet been solved. Standardised suspensions of microparticles in precise concentrations or erythrocyte suspensions with known and constant fibrinogen concentration may be used for this purpose.
The order of the four measurements in the same subject had no effect on the results (see table) . Although repeated measurements of echogenicity gave similar values, the reproducibility of the system needs to be improved. This problem is intraindividual variation, which could be partly solved by prolonging the sampling time to several times longer than one revolution of the roller pump.
Measurement of blood echogenicity can detect samples with considerably raised erythrocyte sedimentation rate (>30 mm in first hour). The 19 of such samples in this study were always very echogenic (relative echogenicity >5500), while samples with a low sedimentation rate (<10 mm in first hour) had a low echogenicity. In fact, in all of the samples with a low sedimentation rate the echogenicity was less than BMJ VOLUME 303 13 JULY 1991 5000 (n=30) except in one sample. Thus there was practically no overlapping between these groups. In the intermediate range there was more variation. Measurement of blood echogenicity could be developed into a fast method for monitoring certain inflammatory diseases and is fairly independent of packed cell volume; the information obtained is similar to that given by the erythrocyte sedimentation rate. Measuring blood echogenicity also allows study of the tendency for erythrocyte aggregation in relation to shear rate, which may be a potentially important variable of blood rheology. A further advantage is that, in theory, blood echogenicity can be measured noninvasivelv in vivo.
I thank Juhani Tuominen for statistical advice. This study was supported by the Technology Development Center, Helsinki, Finland. Objective-To explore the extent to which the relation between plasma cholesterol concentration and risk of death from coronary heart disease in men persists into old age.
Design-18 year follow up of male Whitehall civil servants. Plasma cholesterol concentrations and other risk factors were determined at first examination in 1967-9 when they were aged 40-69. Death of men up to 31 January 1987 was recorded.
Subjects-18296 male civil servants, 4155 of whom died during follow up.
Main outcome measures-Cause and age of death. Cholesterol concentration in 1967-9 and number of years elapsed between testing and death.
Results-1676 men died of coronary heart disease. The mean cholesterol concentration in these men was 0-32 mmol/l higher than that in all other men (95% confidence interval 0-26 to 0-37 mmol/l). This difference in cholesterol concentrations fell 0-15 mmol/l with every 10 years' increase in age at screening. The risk of raised cholesterol concentration fell with age at death. Compared with other men cholesterol concentration in those who died of coronary heart disease was 0-44 mmol/l higher in those who died aged <60 and 0-26 mmol/l higher in those aged 60-79 (p=003). For a given age at death the longer the gap between cholesterol measurement and death the more predictive the cholesterol concentration, both for coronary heart disease and all cause mortality (trend test p=006 and 0-03 respectively).
Conclusion-Reducing plasma cholesterol concentrations in middle age may influence the risk of death from coronary heart disease in old age.
Introduction
Much international effort is being put into changing plasma cholesterol concentrations of whole populations to prevent coronary heart disease.' There is therefore much interest in whether total cholesterol concentration in plasma predicts coronary heart disease in elderly people. In the Framingham study serum cholesterol concentration became less important as a risk factor as the population aged,' although other studies do not agree with this finding.2 If risk factors do not predict disease in elderly people there is little justification for attempting to reduce these risk factors in elderly people.
Most studies examining the predictive value of cholesterol concentration in older people had short follow up so that the age at which cholesterol concentration was measured and the age at death were close. The 18 year follow up of civil servants in the Whitehall study3 enables us to examine how cholesterol concentrations at younger age predict death from coronary disease occurring considerably later.
Subjects and methods
In the Whitehall study 19018 male civil servants aged 40 to 69 were examined during 1967-9.3 The plasma cholesterol concentrations of 18 309 men were measured at entry to the study in a capillary blood sample by using the then standard Technicon method N 24a.' These cholesterol measurements may have been too low for technical reasons, and the overall mean of 5 10 mmol/l in these men is probably an underestimate by 10-15%. The records of the men held at the NHS Central Register were flagged and we were notified of deaths of these men up to 31 January 1987. During this period 13 men died of unknown causes, and we therefore excluded them from all cause-specific analyses. The remaining 18 296 men, who have been followed for a minimum of 18 years since the initial screening, formed the basis for our analysis.
To distinguish between age at screening and age at risk (age at death) during the subsequent follow up, each subject's total follow up period was partitioned
